The World's First and Most Trusted Digital Asset IRA Platform Unveils Seamless Way to Earn Crypto Rewards in Your Retirement…
CCS’s latest evidence-based research reinforces the most innovative and intelligent approaches to improving adherence and outcomes, while reducing the total…
Phase 1 data evaluating VRB-101, Verdiva Bio’s cAMP-biased oral GLP-1RA, provides proof of concept for potential once-weekly oral administration. Preclinical…
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25%…
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was…
HONG KONG, June 03, 2025 (GLOBE NEWSWIRE) -- The International Orthodontics Foundation (IOF), in collaboration with the ADA Forsyth Institute…